Clinical Trial Update: Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

View source ↗

Summary

This completed clinical trial from Beth Israel Medical Center evaluated whether extended platelet parameters can distinguish immune thrombocytopenia from hypo-p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Chemotherapy-induced Thrombocytopenia
• Immune Thrombocytopenia
• Myelodysplastic Syndrome

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Immune Thrombocytopenia, Chemotherapy Induced Thrombocytopenia | Status: COMPLETED